Quoin Pharmaceuticals, Inc. — Form D
Quoin Pharmaceuticals, Inc. of ASHBURN, VA, a company, filed a Form D exempt-offering notice with the SEC on 2020-10-20. The offering totals $3.0M, of which $710K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-10-20
- Form: D
- Accession: 0001829165-20-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $710K
- Remaining: $2.3M
- Minimum investment: $100K
- Investors: 3
- Date of first sale: 2020-10-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-378380
Issuer
- Name: Quoin Pharmaceuticals, Inc.
- CIK: 0001829165
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 42127 PLEASANT FOREST CT., ASHBURN, VA, 20148
- Phone: 703-980-4182
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| DENNIS H LANGER | Director | ASHBURN, VA |
| PETER H LANKAU | Director | ASHBURN, VA |
| Dennis Langer | Director | Naples, FL |
| Michael Meyers | Director | New York, NY |
| Michael Meyers | Executive Officer | New York, NY |
| Denise Carter | Director | Tel Aviv, L3 |
| Denise Carter | Executive Officer | Tel Aviv, L3 |
| Natalie Leong | Director | Tel Aviv, L3 |
| PETER LANKAU | Director | ASHBURN, VA |
Other filings by this issuer (1)
More